These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
550 related articles for article (PubMed ID: 1322242)
1. Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products. Münger K; Scheffner M; Huibregtse JM; Howley PM Cancer Surv; 1992; 12():197-217. PubMed ID: 1322242 [TBL] [Abstract][Full Text] [Related]
2. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses. Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886 [TBL] [Abstract][Full Text] [Related]
3. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252 [TBL] [Abstract][Full Text] [Related]
4. Induction of the p53-target gene GADD45 in HPV-positive cancer cells. Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059 [TBL] [Abstract][Full Text] [Related]
5. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer. Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297 [TBL] [Abstract][Full Text] [Related]
6. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506 [TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes. Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644 [TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of transformation by the human papillomaviruses. Howley PM; Münger K; Werness BA; Phelps WC; Schlegel R Princess Takamatsu Symp; 1989; 20():199-206. PubMed ID: 2562182 [TBL] [Abstract][Full Text] [Related]
9. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. Rampias T; Sasaki C; Weinberger P; Psyrri A J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448 [TBL] [Abstract][Full Text] [Related]
10. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma. Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542 [TBL] [Abstract][Full Text] [Related]
11. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA. DiPaolo JA; Popescu NC; Alvarez L; Woodworth CD Crit Rev Oncog; 1993; 4(4):337-60. PubMed ID: 8394744 [TBL] [Abstract][Full Text] [Related]
12. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Jiang M; Milner J Oncogene; 2002 Sep; 21(39):6041-8. PubMed ID: 12203116 [TBL] [Abstract][Full Text] [Related]
13. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells. Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117 [TBL] [Abstract][Full Text] [Related]
14. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer. Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681 [TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins. Yugawa T; Kiyono T Rev Med Virol; 2009 Mar; 19(2):97-113. PubMed ID: 19156753 [TBL] [Abstract][Full Text] [Related]
16. Comparative study on E6 and E7 genes of some cutaneous and genital papillomaviruses of human origin for their ability to transform 3Y1 cells. Hiraiwa A; Kiyono T; Segawa K; Utsumi KR; Ohashi M; Ishibashi M Virology; 1993 Jan; 192(1):102-11. PubMed ID: 8390746 [TBL] [Abstract][Full Text] [Related]
17. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells. Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855 [TBL] [Abstract][Full Text] [Related]
18. HPV18 E6 and E7 genes affect cell cycle, pRB and p53 of cervical tumor cells and represent prominent candidates for intervention by use peptide nucleic acids (PNAs). Braun K; Ehemann V; Waldeck W; Pipkorn R; Corban-Wilhelm H; Jenne J; Gissmann L; Debus J Cancer Lett; 2004 Jun; 209(1):37-49. PubMed ID: 15145519 [TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells. Pim D; Storey A; Thomas M; Massimi P; Banks L Oncogene; 1994 Jul; 9(7):1869-76. PubMed ID: 8208532 [TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus E6 and E7: proteins which deregulate the cell cycle. Tommasino M; Crawford L Bioessays; 1995 Jun; 17(6):509-18. PubMed ID: 7575492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]